Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
Open Access
- 28 August 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 7 (1), 99
- https://doi.org/10.1186/1471-2334-7-99
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Clinical, Immunological, and Epidemiological Importance of Antituberculosis T Cell Responses in HIV-Infected AfricansClinical Infectious Diseases, 2007
- Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected IndividualsAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Undiagnosed Tuberculosis in a Community with High HIV PrevalenceAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program EvaluationClinical Infectious Diseases, 2006
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006
- Quantitative T Cell Assay Reflects Infectious Load of Mycobacterium tuberculosis in an Endemic Case Contact ModelClinical Infectious Diseases, 2005
- Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2004
- Effector and memory T-cell differentiation: implications for vaccine developmentNature Reviews Immunology, 2002
- Long‐Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from TuberculosisClinical Infectious Diseases, 2001
- A Mycobacterium tuberculosis operon encoding ESAT=6 and a novel low-molecular-mass culture filtrate protein (CFP-10)Microbiology, 1998